 |
|
|
Considering aesthetic surgery? You need to do your research and become an informed consumer.
Home
Information about Anti-Aging Products and Their Active
Ingredients
WRINKLE RELAX
TRIA LASER HAIR REMOVAL SYSTEM
Hydroderm
Strivectin Eye Cream Celebrity Plastic
Surgery Celebrity Cosmetic Surgery Whose Had it??
Bion Ceramic Flat Iron
GoSMILE TOOTH WHITENING
FROWNIES
HOLLYWOOD'S BEST
KEPT SECRET
RICAUD
TRUE COSMETICS
BEING TRUE
|
Valeant Pharmaceuticals Announces Strategic Brand-Building and Line-Extension Initiatives for Kinerase(R)(press release from Valeant Pharmaceuticals International) COSTA MESA, Calif., June 3 -- Valeant Pharmaceuticals (NYSE:VRX) announced plans to build the Kinerase(R) brand and expand this important product line in 2004. Kinerase contains Kinetin, the same natural substance that helps plants retain moisture and has been shown to reduce the appearance of fine lines and wrinkles. Keeping in line with its strategic plan and focusing on its dermatology platform, Valeant is building the Kinerase franchise into a global product line by launching a series of line extensions, expanding into new markets and increasing promotional activities around the brand.
Valeant has already taken a number of steps to increase brand visibility
by launching Kinerase Intensive Eye Cream earlier this year, stepping up
promotional activities, acquiring global rights to Kinerase and gaining rights
to license Zeatin, a naturally occurring analogue of Kinetin, as a future
extension of the Kinerase brand. Valeant also plans to launch Kinerase Cream
with SPF 15, Kinerase Gentle Daily Cleanser and an innovative Kinerase complex
containing vitamin C later in the year. A Kinerase men's line is also in the
works for the future. "Kinerase is an important product line for Valeant, and we are working to expand the product's portfolio for our customers," President and Chief Operating Officer, Timothy C. Tyson said. "With the acquisition of worldwide rights to Kinerase and our recent licensing deal with Senetek for Zeatin, along with our intensive efforts to launch all of these line extensions in 2004, we will be able to provide an entire line of skin-care products for Kinerase users. We have also been encouraged to see an increase in demand for Kinerase products within the celebrity community." The launch of Kinerase Intensive Eye Cream earlier this year is a complement to the cream and lotion already sold in the U.S. market. The eye cream is formulated with a 25 percent higher concentration of Kinetin than the cream and lotion, the substance used in Kinerase that helps skin retain moisture and reduces the appearance of fine lines and wrinkles. As a result of its newly acquired worldwide rights to Kinerase, Valeant recently launched the eye cream and cream products in the European market. Valeant will continue to roll out the Kinerase product line through physicians, dermatologists and pharmacists in the European market throughout 2004 and 2005. "I recommend Kinerase products to my patients who have recently undergone cosmetic procedures, laser treatments or those simply wanting to improve the appearance of their skin," said Dr. Bruce Katz, M.D., Clinical Professor, Mt. Sinai School of Medicine, Director, Juva Skin & Laser Center and Director, Cosmetic Surgery & Laser Clinic Mt. Sinai Hospital. "Kinerase is an excellent product and I look forward to having an entire line of products to recommend to my patients." In the summer of 2004, Dr. Katz will be conducting a study to determine the effects of Kinerase products on facial and neck skin. All of the Kinerase line-extension products are gentle and non-irritating and can be used in combination with other facial products.
In a 24-week study of the Kinerase cream, 90 percent of participants
reported an improvement in the texture of their skin and 87 percent reported
an overall improvement in the appearance of their skin. Kinerase Cream and Lotion have been marketed by Valeant Pharmaceuticals in the U.S. since 1999. The product has shown substantial recent growth, with 2003 gross sales reaching $10.9 million. The product is distributed primarily through dermatologists and plastic surgeons and is also available behind-the-counter at select pharmacies. Kinerase can be purchased online at www.kinerase.com. About Valeant Valeant Pharmaceuticals International is a global, publicly traded, research-based specialty pharmaceutical company that discovers, develops, manufactures and markets a broad range of pharmaceutical products. More information about Valeant can be found at: www.valeant.com. FORWARD-LOOKING STATEMENT This press release contains forward-looking statements within the meaning of the federal securities laws relating to expectations, plans or prospects for Valeant Pharmaceuticals. These statements are based upon the current expectations and beliefs of Valeant Pharmaceuticals' management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include market acceptance of new products and other market conditions and factors beyond Valeant Pharmaceuticals' control, the company's ability to develop successfully and introduce line extensions, and the risk factors and other cautionary statements discussed in Valeant Pharmaceuticals' filings with the U.S. Securities and Exchange Commission.
For further information, please contact: Jeff Misakian of Valeant
Pharmaceuticals International, +1-714-545-0100, ext. 3309. *********** If You Found this Article Helpful You May Enjoy this article:
OLD VITAMINS
LEARN NEW TRICKS
and |
PROACTIV SOLUTION ACNE TREATMENT
|
|
Type in your search words below
|
All contents copyright ©2000-2011
- Cosmetic Surgery News - All rights reserved.